Navigation Links
International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification

COLUMBIA, S.C., March 9 /PRNewswire/ -- Conformity markings allow Rhythmlink International products to be marketed throughout Europe, launching Rhythmlink to a new level within the neurodiagnostic and health care industry.

As of January 28, 2010, Rhythmlink International received ISO 13485:2003 certification, in combination with official CE markings, following MDD 93/42/ECC Directives. Rhythmlink's quality management system was audited in accordance with ISO 13485:2003 and is recognized by the Canadian Medical Devices Conformity Assessment Scheme [CMDCAS] and the Standards Council of Canada [SCC] accredited notified body, TUV Rheinland.

Effective immediately, Rhythmlink may sell and market product within the European Union [EU] and partnering nations. "Our ISO 13485:2003 certification is key to the growth of the company. This certification demonstrates to the markets in the European Union that Rhythmlink will provide products backed by a quality management system that reduces risk to patients," said Martin Barry, Rhythmlink International's regulatory affairs specialist.

As an electrode manufacturing company, within the medical devices industry, Rhythmlink International is bound by strict FDA regulations and regulatory requirements. Rhythmlink's quality management system has demonstrated the ability to provide medical devices and services that consistently achieve customer and regulatory requirements, thus receiving ISO 13485:2003 certification and ISO 13485:2003 + AC:2007 CE Markings.

Under European Directives and supported by European standards, Rhythmlink and its products are in full compliance with essential health and safety requirements. The CE Marking is Rhythmlink's declaration that all products meet the essential requirements of the European directives.

For more information about Rhythmlink's certifications, products and services, visit

About Rhythmlink International, LLC

Rhythmlink International, LLC designs, manufactures and distributes neurodiagnostic accessories and provides custom OEM and manufacturing solutions to its customers.  Based in Columbia, S.C., Rhythmlink was established in 2002 and is owned and operated by CEO Shawn Regan and COO Michael O'Leary.  Rhythmlink's advancements and improvements in the areas of technology, business development and corporate branding have been recognized by entities such as the Columbia Information Technology Council, Inc. Magazine and the International Academy of the Visual Arts.  For more information about Rhythmlink International, its products or services, visit

SOURCE Rhythmlink International, LLC

Back to top



SOURCE Rhythmlink International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
2. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
3. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
4. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
5. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
6. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
7. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
8. Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International
9. International Merchant Advisors, Inc. Signs LOI to Invest in Pharmaceutical Chain
10. Max Neeman International Expands Specialized Surgical Team for Clinical Trials
11. Bacterin International Completes $3 Million Private Placement
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology:
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction ... , “We wake up every day excited to rebuild lives and it’s an honor ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact ... and reliability. , The new Q-Suite 6 platform is based on the latest Java ... into a specific piece of software for many key components of the suite. Much ...
Breaking Medicine News(10 mins):